Paroxetine increases brain-derived neurotrophic factor in postmenopausal women

Menopause

Volumn 17, Issue 2, 2010, Pages 338-343

  Cubeddu, Alessandra ^a   Giannini, Andrea ^a   Bucci, Fiorella ^a   Merlini, Sara ^a   Pluchino, Nicola ^a   Luisi, Stefano ^b   Luisi, Michele ^a   Genazzani, Andrea R ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Brain derived neurotrophic factor; Menopause; Paroxetine

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; ESTRADIOL VALERATE; ESTRADIOL VALERATE PLUS NORGESTREL; PAROXETINE;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; COGNITION; DRUG EFFECT; ENDOCRINE FUNCTION; FEMALE; FOLLOW UP; HORMONAL THERAPY; HUMAN; HUMAN EXPERIMENT; MENOPAUSAL SYNDROME; MENOPAUSE; POSTMENOPAUSE; QUESTIONNAIRE; SCORING SYSTEM;

BRAIN-DERIVED NEUROTROPHIC FACTOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTRADIOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEVONORGESTREL; MIDDLE AGED; PAROXETINE; POSTMENOPAUSE; QUESTIONNAIRES; SEROTONIN UPTAKE INHIBITORS;

EID: 77949382901     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181c29e44     Document Type: Article

References (46)

1. National Institutes of Health. National Institutes of Health State-of-the-Science Conference statement: management of menopause-related symptoms. Ann Intern Med 2005;142:1003-1013.
2. Ganz PA, Rowland JH, Desmond K, et al. Life after breast cancer: understanding women's health-related quality of life and sexual functioning. J Clin Oncol 2008;16:501-514.
3. Warren MP. Missed symptoms of menopause. Int J Clin Pract 2007;61: 2041-2050.
4. Randolph JF Jr, Sowers M, Bondarenko I, et al. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition. J Clin Endocrinol Metab 2005;90: 6106GF-6112GF.
5. Gonzales GF, Carrillo C. Blood serotonin levels in postmenopausal women: effects of age and serum estradiol levels. Maturitas 1993;17: 23-29.
6. Blum I, Vered Y, Lifshitz A, et al. The effect of estrogen replacement therapy on plasma serotonin and catecholamines of postmenopausal women. Isr J Med Sci 1996;32:1158-1162.
7. Halbreich U, Rojanski N, Palter S, et al. Estrogen augments serotonergic activity in postmenopausal women. Biol Psychiatry 1995;37:434-441.
8. Bourin M, David DJ, Jolliet P, Gardier A. Mechanism of action of antidepressants and therapeutic perspectives. Therapie 2002;57:385-396.
9. Altar CA, Cai N, Bliven T, et al. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 1997;389: 856-860.
10. Hefti F, Knusel B, Lapchak PA. Protective effects of nerve growth factor and brain-derived neurotrophic factor on basal forebrain choliner-gic neurons in adult rats with partial fimbrial transections. Prog Brain Res 1993;98:257-263.
11. Lindsay RM. Neurotrophic growth factors and neurodegenerative diseases: therapeutic potential of the neurotrophins and ciliary neurotrophic factor. Neurobiol Aging 1994;15:249-251.
12. Begliuomini S, Casarosa E, Pluchino N, et al. Influence of endogenous and exogenous sex hormones on plasma brain-derived neurotrophic factor. Hum Reprod 2007;22:995-1002.
13. Tapia-Arancibia L, Rage F, Givalois L, Arancibia S. Physiology of BDNF: focus on hypothalamic function. Front Neuroendocrinol 2004; 25:77-107.
14. Kimmick GG, Lovato J, McQuellon R, et al. Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking ta-moxifen. Breast J 2006;12:114-122.
15. Loprinzi CL, Sloan JA, Perez EA, et al. Phase III evaluation of flu-oxetine for treatment of hot flashes. J Clin Oncol 2002;20:1578-1583.
16. Stearns V, Beebe KL, Iyengar M, et al. Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial. JAMA 2003;289:2827-2834.
17. Stearns V, Slack R, Greep N, et al. Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial. J Clin Oncol 2005;23:6919-6930.
18. Deltheil T, Guiard BP, Guilloux JP, et al. Consequences of changes in BDNF levels on serotonin neurotransmission, 5-HT transporter expression and function: studies in adult mice hippocampus. Pharmacol Biochem Behav 2008;90:174-183.
19. Martinowich K, Lu B. Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology 2008;33:73-83.
20. Shimizu E, Hashimoto K, Okamura N, et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 2003;54:70-75.
21. Soules MR, Sherman S, Parrott E, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Climacteric 2001;4:267-272.
22. Greene JG. Constructing a standard climacteric scale Maturitas 1998; 29:25-31
23. Solum DT, Handa RJ. Estrogen regulates the development of brain-derived neurotrophic factor mRNA and protein in the rat hippocampus. J Neurosci 2002;22:2650-2659.
24. Lu B, Chow A. Neurotrophins and hippocampal synaptic transmission and plasticity. J Neurosci Res 1999;58:76-87.
25. Mattson MP, Maudsley S, Martin B. BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci 2004;27:589-594.
26. Bekinschtein P, Cammarota M, Igaz LM, Bevilaqua LR, Izquierdo I, Medina JH. Persistence of long-term memory storage requires a late protein synthesis-and BDNF-dependent phase in the hippocampus. Neuron 2007;53:261-277.
27. Vaynman S, Ying Z, Gomez-Pinilla F. Hippocampal BDNF mediates the efficacy of exercise on synaptic plasticity and cognition. Eur J Neurosci 2004;20:2580-2590.
28. Komulainen P, Pedersen M, Hänninen T, et al. BDNF is a novel marker of cognitive function in ageing women: the DR's EXTRA Study. Neurobiol Learn Mem 2008;90:596-603.
29. Soares CN, Joffe H, Viguera AC, et al. Paroxetine versus placebo for women in midlife after hormone therapy discontinuation. Am J Med 2008;121:159-162.
30. Mamounas LA, Blue ME, Siuciak JA, Altar CA. Brain-derived neuro-trophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J Neurosci 1995;15:7929-7939.
31. Mamounas LA, Altar CA, Blue ME, Kaplan DR, Tessarollo L, Lyons WE. BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain. J Neurosci 2000;20: 771-782.
32. Siuciak JA, Boylan C, Fritsche M, Altar CA, Lindsay RM. BDNF increases monoaminergic activity in rat brain following intracerebroven-tricular or intraparenchymal administration. Brain Res 1996;710:11-20.
33. Goggi J, Pullar IA, Carney SL, Bradford HF. Modulation of neuro-transmitter release induced by brain-derived neurotrophic factor in rat brain striatal slices in vitro. Brain Res 2002;941:34-42.
34. Galter D, Unsicker K. Sequential activation of the 5-HT1(A) serotonin receptor and TrkB induces the serotonergic neuronal phenotype. Mol Cell Neurosci 2000;15:446-455.
35. Connor B, Young D, Yan Q, Faull RL, Synek B, Dragunow M. Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Brain Res Mol Brain Res 1997;49:71-81.
36. Parain K, Murer MG, Yan Q, et al. Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra. Neuroreport 1999;10:557-561.
37. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 2002;109:143-148.
38. Toyooka K, Asama K, Watanabe Y, et al. Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients. Psychiatry Res 2002;110:249-257.
39. Ichikawa H, Yabuuchi T, Jin HW, et al. Brain-derived neurotrophic factor-immunoreactive primary sensory neurons in the rat trigeminal ganglion and trigeminal sensory nuclei. Brain Res 2006;1081:113-118.
40. Conner JM, Lauterborn JC, Yan Q, Gall CM, Varon S. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J Neurosci 1997;17:2295-2313.
41. Bruns MB, Miller MW. Neurotrophin ligand-receptor systems in somatosensory cortex of adult rat are affected by repeated episodes of ethanol. Exp Neurol 2007;204:680-692.
42. Fryer RH, Kaplan DR, Feinstein SC, Radeke MJ, Grayson DR, Kromer LF. Developmental and mature expression of full-length and truncated TrkB receptors in the rat forebrain. J Comp Neurol 1996;374:21-40.
43. Merighi A, Salio C, Ghirri A, et al. BDNF as a pain modulator. Prog Neurobiol 2008;85:297-317.
44. von Bartheld CS, Wang X, Butowt R. Anterograde axonal transport, transcytosis, and recycling of neurotrophic factors: the concept of trophic currencies in neural networks. Mol Neurobiol 2001;24:1-28.
45. 2+ block extends the action of NT-3 on synaptic transmission in neonatal rat motoneurons. J Neurophysiol 2001;86:123-129.
46. Bardoni R, Ghirri A, Salio C, Prandini M, Merighi A. BDNF-mediated modulation of GABA and glycine release in dorsal horn lamina II from postnatal rats. Dev Neurobiol 2007;67:960-975.